Atom Investors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Atom Investors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-20,157	Closed	-$498K	–	452
2020 Q4	$498K	Sell	20,157 -41,896	-68%	-$1.39M	0.05%	244
2020 Q3	$2.57M	Buy	62,053 +22,818	+58%	+$1.05M	0.25%	97
2020 Q2	$1.88M	Buy	39,235 +10,077	+35%	+$778K	0.12%	143
2020 Q1	$1.84M	Sell	29,158 -53,704	-65%	-$4.83M	0.16%	115
2019 Q4	$10.3M	Sell	82,862 -34,681	-30%	-$3.1M	0.84%	39
2019 Q3	$7.8M	Buy	+117,543	New	+$7.89M	0.53%	57

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Atom Investors's ICPT Position: Q1 2021 in Review

Atom Investors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 20,157 shares — an estimated $498K sold.

Atom Investors first reported a position in ICPT in Q3 2019 and held it in 6 quarters. The position peaked at $10.3M in Q4 2019. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Atom Investors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Atom Investors sold 20,157 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $498K.
Atom Investors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2019 and held it in 6 quarters.
Atom Investors's Intercept Pharmaceuticals, Inc. position peaked at $10.3M in Q4 2019.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Atom Investors's 13F filing for Q1 2021, filed 17 May 2021.